
2.03 Delayed Data As of Jul 01 | ![]() Today’s Change | 1.01 Today|||52-Week Range 2.32 | +43.97% Year-to-Date |
The 2 analysts offering 12-month price forecasts for ADMA Biologics Inc have a median target of 4.75, with a high estimate of 5.00 and a low estimate of 4.50. The median estimate represents a +133.99% increase from the last price of 2.03.
The current consensus among 2 polled investment analysts is to Buy stock in ADMA Biologics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.